FINWIRES · TerminalLIVE
FINWIRES

杰德斯通公司获得越南气田天然气销售协议,目标2028年产量

-- Jadestone Energy周一宣布,已签署一项针对其越南气田的天然气销售协议,目标日产量为8000万标准立方英尺,预计将于2028年底投产。 该公司表示,该协议涵盖来自越南西南部近海Nam Du和U Minh气田的天然气供应。 该公司补充说,该协议符合2026年3月18日批准的开发计划,目标是在2028年底实现首次投产。 Jadestone表示,根据协议,天然气将按照既定的供应和定价条款出售给越南国家石油公司(Petrovietnam)旗下的PV Gas公司。 该公司补充说,合同规定日供应量为8000万标准立方英尺,并具有高达110%的灵活性,以及涵盖90%供应量的照付不议条款。 Jadestone表示,定价与越南历史天然气进口水平挂钩,协议中包含年度价格递增条款,以确保长期收入的可预测性。 该公司指出,这些油田拥有约3200万桶油当量探明和概算储量,具备长期生产潜力。 Jadestone公司还表示,附近油田也蕴藏着巨大的增值潜力,预计可额外提供高达1.5万亿立方英尺的天然气,这有望延长产量稳定期并提升项目价值。 首席执行官T. Mitch Little表示,该协议是Jadestone公司发展历程中的一个重要里程碑,有助于推进项目执行,重点在于合同授予,同时支持越南的能源安全、经济增长和长期减排目标。

Related Articles

Asia

National Australia Bank Shares Down After Resolution of Union Court Proceedings

National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."

$ASX:NAB
Asia

Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant

Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.

$ASX:CUV
Asia

XRF Scientific Completes Acquisition of Combustion Gas Analysis Business

XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.

$ASX:XRF